Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Net Margin (2016 - 2025)

Macrogenics (MGNX) has disclosed Net Margin for 14 consecutive years, with 34.27% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 193.0% to 34.27% in Q4 2025 year-over-year; TTM through Dec 2025 was 51.96%, a 8320.0% increase, with the full-year FY2025 number at 49.89%, down 524.0% from a year prior.
  • Net Margin was 34.27% for Q4 2025 at Macrogenics, down from 23.09% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 23.09% in Q3 2025 to a low of 1686.79% in Q2 2024.
  • A 5-year average of 322.58% and a median of 303.85% in 2021 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: crashed -133861bps in 2024, then soared 151744bps in 2025.
  • Macrogenics' Net Margin stood at 411.65% in 2021, then soared by 104bps to 16.39% in 2022, then crashed by -2908bps to 460.39% in 2023, then surged by 92bps to 36.19% in 2024, then grew by 5bps to 34.27% in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Net Margin are 34.27% (Q4 2025), 23.09% (Q3 2025), and 169.35% (Q2 2025).